Omicron Variant B.1.1.529 Peptide Pool SARS-CoV-2 (Spike Glycoprotein)

Omicron Variant B.1.1.529 Peptide Pool SARS-CoV-2 (Spike Glycoprotein)


Order number: P2781.0080

Shipping: Shipment: not cooled. Store at -20°C. For laboratory usage only!

Delivery time: 3- 8 working days
For detailed information on the delivery date, please contact Genaxxon.

€283.25 *
This peptide pool with 80 peptides covers all mutations in the Spike Glycoprotein derived from... more
Product information "Omicron Variant B.1.1.529 Peptide Pool SARS-CoV-2 (Spike Glycoprotein)"

This peptide pool with 80 peptides covers all mutations in the Spike Glycoprotein derived from the omicron variant B.1.1.529 of SARS-CoV-2.

The peptides of this product are supplied lyophilized as trifluoro
acetate salts.
This pool consists of 80 peptides of the spike protein and covers only
the mutations of the new omicron variant of SARS-CoV-2 (B.1.1.529).

Possilbe applications: T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response.

Each peptide is purified by solid phase extraction and checked on its purity by ESI-MS.

Peptide sequences - total length: 1273 amino acids

DLFLPFFSNVTWFHV; RQIAPGQTGNIADYN; VAVLYQGVNCTEVPV; PFFSNVTWFHVISGT; PGQTGNIADYNYKLP; YQGVNCTEVPVAIHA; NVTWFHVISGTNGTK;
GNIADYNYKLPDDFT; QTRAGCLIGAEYVNN; FHVISGTNGTKRFDN; DFTGCVIAWNSNKLD; GCLIGAEYVNNSYEC; VLPFNDGVYFASIEK; CVIAWNSNKLDSKVS;
GAEYVNNSYECDIPI; NDGVYFASIEKSNII; WNSNKLDSKVSGNYN; AGICASYQTQTKSHR; YFASIEKSNIIRGWI; KLDSKVSGNYNYLYR; ASYQTQTKSHRRARS;
IEKSNIIRGWIFGTT; KVSGNYNYLYRLFRK; TQTKSHRRARSVASQ; CEFQFCNDPFLDHKN; FERDISTEIYQAGNK; SHRRARSVASQSIIA; FCNDPFLDHKNNKSW;
ISTEIYQAGNKPCNG; LLLQYGSFCTQLKRA; PFLDHKNNKSWMESE; IYQAGNKPCNGVAGF; YGSFCTQLKRALTGI; DGYFKIYSKHTPIIV; GNKPCNGVAGFNCYF;
CTQLKRALTGIAVEQ; KIYSKHTPIIVREPE; CNGVAGFNCYFPLKS; KRALTGIAVEQDKNT; KHTPIIVREPEDLPQ; AGFNCYFPLKSYSFR; QVKQIYKTPPIKYFG;
IIVREPEDLPQGFSA; CYFPLKSYSFRPTYG; IYKTPPIKYFGGFNF; EPEDLPQGFSALEPL; LKSYSFRPTYGVGHQ; PPIKYFGGFNFSQIL; RFPNITNLCPFDEVF;
SFRPTYGVGHQPYRV; YFGGFNFSQILPDPS; ITNLCPFDEVFNATR; TYGVGHQPYRVVVLS; IAARDLICAQKFKGL; CPFDEVFNATRFASV; GHQPYRVVVLSFELL;
DLICAQKFKGLTVLP; NCVADYSVLYNLAPF; NKCVNFNFNGLKGTG; AQKFKGLTVLPPLLT; DYSVLYNLAPFFTFK; NFNFNGLKGTGVLTE; KGLTVLPPLLTDEMI;
LYNLAPFFTFKCYGV; NGLKGTGVLTESNKK; STASALGKLQDVVNH; APFFTFKCYGVSPTK; PGTNTSNQVAVLYQG; ALGKLQDVVNHNAQA; GDEVRQIAPGQTGNI;
TSNQVAVLYQGVNCT; LQDVVNHNAQALNTL; VNHNAQALNTLVKQL; AQALNTLVKQLSSKF; NTLVKQLSSKFGAIS; KQLSSKFGAISSVLN; SKFGAISSVLNDIFS;
AISSVLNDIFSRLDK; VLNDIFSRLDKVEAE; IFSRLDKVEAEVQID

More products around "Omicron Variant B.1.1.529 Peptide Pool SARS-CoV-2 (Spike Glycoprotein)"
Gene: S   No Peptides: 80 peptides   Amount Peptide: 25 µg... more
 

Technical Data:

Gene: S  
No Peptides: 80 peptides  
Amount Peptide: 25 µg  
Amount Aliquote: 2,0 mg  
Uniprot Id: P0DTC2  
Solubility: Dissolve in a minimum amount of pure DMSO (approx. 40μl) and dilute with water to the desired concentration. Please pay attention that the final concentration of DMSO must be below 1% (v/v) to avoid toxicity in the biological  
Storage: Store at -20°C  
Delivery: 2-3 days  
Purity: Each peptide ESI-MS checked, pool is purified by solid phase extraction  
Counter Ion: TFA  
Protein: Spike glycoprotein  
Species: Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)  
Application : T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response  
Indication : Covid-19, Infection, Respiratory infection  

application:

T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response

Source

synthetic

Sicherheits Hinweise / Safety

Klassifizierungen / Classification

eclass-Nr: 32-16-04-09
Dokumente - Protokolle - Downloads more


Dokumente - Protokolle - Downloads

Here you will find information and further literature on Omicron Variant B.1.1.529 Peptide Pool SARS-CoV-2 (Spike Glycoprotein). For further documents (certificates with additional lot numbers, safety data sheets in other languages, further product information) please contact Genaxxon biosience at: info@genaxxon.com or phone: +49 731 3608 123.